It has long been known that a hallmark of Alzheimer's disease, and most other neurodegenerative diseases, is the clumping together of insoluble protein aggregates in the brain. During normal disease-free aging, there is also ...
May 16, 2024
0
1
Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Mar 8, 2024
0
10
Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis, according ...
Mar 2, 2024
0
45
Alzheimer's quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes—a potential window to one day intervene.
Feb 22, 2024
0
2
A new research paper titled "GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects" has been published in Aging.
Feb 15, 2024
0
21
UNC School of Medicine researcher Sarah Cohen, Ph.D., and Ian Windham, a former Ph.D. student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE)—the biggest genetic risk factor for late-onset Alzheimer's ...
Feb 9, 2024
0
64
A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.
Jan 31, 2024
0
15
The prevailing theory on the causes of Alzheimer's disease indicates that they are related to the abnormal accumulation of two proteins, amyloid-beta (Aβ) and tau, in neuronal tissues, but there are still many unknowns concerning ...
Jan 17, 2024
0
0
The passing of June's summer solstice, the longest day of the year, prompts reflection on all of the ways people work to shine a light in the darkness. June is also Alzheimer's Awareness Month, a time in which we strive to ...
Jul 31, 2023
0
36
A second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.
Jul 22, 2023
0
9
